Commit Biologics raises €54M
Commit Biologics announced a Seed round of €54M on 17 November 2026. The company operates in HealthTech and is based in Denmark. It was founded by Thomas L. F. Montgomery Andresen, CEO. Announced 3 days ago.
Founder
Thomas L. F. Montgomery Andresen
CEO, Commit Biologics
Outreach angles
- -Dr Thomas L. F. Montgomery Andresen was appointed CEO of Commit Biologics in March 2026.
- -Andresen is taking COM002, a first-in-class immune engager that works independently of T cells, towards the clinic.
- -The seed was led by Ackermans & van Haaren, with AbbVie Ventures and M Ventures joining Novo Holdings and other existing backers.
Signals
SeedDeep TechHealthcareRegulated Industry
Round details
Company: Commit Biologics
Domain: commitbio.com
Amount: €54M
Stage: Seed
Industry: HealthTech
Country: Denmark
Announced: 17 November 2026
Other HealthTech raises
Recently funded in Denmark